Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 26, 2020 Filed Mar 27, 2020 11:47 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,789 | $5.46 | $9,759.00 |
DisclosureSEC source: 0001393726-20-000059 · wf-form4_158532401729847.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,216,113 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.35 to $5.58, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 26, 2020 Filed Mar 27, 2020 11:43 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.50 | $1,100.00 |
DisclosureSEC source: 0001393726-20-000057 · wf-form4_158532378341265.xml · nonDerivative · entry 2 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,635 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 25, 2020 Filed Mar 27, 2020 11:47 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,789 | $5.62 | $10,061.34 |
DisclosureSEC source: 0001393726-20-000059 · wf-form4_158532401729847.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,214,324 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.54 to $5.68, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 25, 2020 Filed Mar 27, 2020 11:43 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.17 | $1,034.00 |
DisclosureSEC source: 0001393726-20-000057 · wf-form4_158532378341265.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,835 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 24, 2020 Filed Mar 25, 2020 10:18 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,789 | $5.05 | $9,034.45 |
DisclosureSEC source: 0001393726-20-000055 · wf-form4_158514588035909.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,212,535 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.90 to $5.19, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 24, 2020 Filed Mar 25, 2020 10:16 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $4.95 | $990.00 |
DisclosureSEC source: 0001393726-20-000053 · wf-form4_158514576291914.xml · nonDerivative · entry 2 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,035 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 23, 2020 Filed Mar 25, 2020 10:18 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,789 | $4.70 | $8,415.46 |
DisclosureSEC source: 0001393726-20-000055 · wf-form4_158514588035909.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,210,746 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.59 to $4.82, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 23, 2020 Filed Mar 25, 2020 10:16 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $4.68 | $936.00 |
DisclosureSEC source: 0001393726-20-000053 · wf-form4_158514576291914.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,235 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 20, 2020 Filed Mar 23, 2020 10:31 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,259 | $4.87 | $6,128.81 |
DisclosureSEC source: 0001393726-20-000051 · wf-form4_158497388999965.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,208,957 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.80 to $4.90, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 20, 2020 Filed Mar 23, 2020 10:26 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $4.90 | $980.00 |
DisclosureSEC source: 0001393726-20-000049 · wf-form4_158497357712258.xml · nonDerivative · entry 2 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,435 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 10:31 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,259 | $5.07 | $6,381.87 |
DisclosureSEC source: 0001393726-20-000051 · wf-form4_158497388999965.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,207,698 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.90 to $5.19, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 10:26 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.19 | $1,038.00 |
DisclosureSEC source: 0001393726-20-000049 · wf-form4_158497357712258.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,635 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 09:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,259 | $6.26 | $7,881.34 |
DisclosureSEC source: 0001393726-20-000045 · wf-form4_158462448520277.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,206,439 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.18 to $6.36, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 09:30 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $6.36 | $1,272.00 |
DisclosureSEC source: 0001393726-20-000047 · wf-form4_158462462310877.xml · nonDerivative · entry 2 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,835 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 09:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,259 | $5.72 | $7,201.48 |
DisclosureSEC source: 0001393726-20-000045 · wf-form4_158462448520277.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,205,180 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 09:30 UTC |
Bell SandraChief Financial Officer
|
SaleCommon Stock | 200 | $5.72 | $1,144.00 |
DisclosureSEC source: 0001393726-20-000047 · wf-form4_158462462310877.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,035 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 13:48 UTC |
Ilany JonathanDirector · Chief Executive Officer
|
PurchaseCommon Stock | 3,900 | $6.25 | $24,375.00 |
DisclosureSEC source: 0001393726-20-000043 · wf-form4_158445288364168.xml · nonDerivative · entry 2 Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 29,440 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 13:48 UTC |
Ilany JonathanDirector · Chief Executive Officer
|
PurchaseCommon Stock | 690 | $5.25 | $3,622.50 |
DisclosureSEC source: 0001393726-20-000043 · wf-form4_158445288364168.xml · nonDerivative · entry 1 Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 25,540 Read SEC document |
| March 02, 2020 Filed Mar 2, 2020 15:09 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,948 | $6.71 | $19,786.98 |
DisclosureSEC source: 0001393726-20-000034 · wf-form4_158317976842213.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,203,921 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $6.66 to $6.79, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 15:09 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 24,078 | $6.79 | $163,561.85 |
DisclosureSEC source: 0001393726-20-000034 · wf-form4_158317976842213.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,200,973 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.63 to $6.85, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 15:00 UTC |
Bell SandraChief Financial Officer
|
Tax withholdingCommon Stock | 6,910 | $6.58 | $45,467.80 |
DisclosureSEC source: 0001393726-20-000030 · wf-form4_158317922705821.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,235 F1 · kind: Represents the total amount of shares withheld upon vesting of (1) the third and final of installment of restricted stock units issued to the Reporting Person on February 22, 2017, (2) the second installment of restricted stock units issued to the Reporting Person on February 26, 2018, and (3) the first installment of restricted stock units issued to the Reporting Person on February 26, 2019. F2 · price: Represents the closing stock price as of the transaction date. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 15:06 UTC |
Rifkind Neil CharlesGeneral Counsel and Secretary
|
Tax withholdingCommon Stock | 7,219 | $6.58 | $47,501.02 |
DisclosureSEC source: 0001393726-20-000032 · wf-form4_158317956490703.xml · nonDerivative · entry 1 Rifkind Neil Charles · CIK 0001580685 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,485 F1 · kind: Represents the total amount of shares withheld upon vesting of (1) the third and final installment of restricted stock units issued to the Reporting Person on February 22, 2017, (2) the second installment of restricted stock units issued to the Reporting Person on February 26, 2018, and (3) the first installment of restricted stock units issued to the Reporting Person on February 26, 2019. F2 · price: Represents the closing stock price as of the transaction date. Read SEC document |
| February 27, 2020 Filed Feb 27, 2020 17:11 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 20,476 | $6.85 | $140,178.70 |
DisclosureSEC source: 0001393726-20-000028 · wf-form4_158284149497934.xml · nonDerivative · entry 3 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,176,895 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.83 to $6.85, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 17:11 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 702 | $6.85 | $4,808.70 |
DisclosureSEC source: 0001393726-20-000028 · wf-form4_158284149497934.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,156,419 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 17:11 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,943 | $6.85 | $20,159.55 |
DisclosureSEC source: 0001393726-20-000028 · wf-form4_158284149497934.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,155,717 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 22:11 UTC |
Ilany JonathanDirector · Chief Executive Officer
|
GrantEmployee Stock Option · Derivative | 255,166 | $0.00 Strike: $7.25 | $0.00 |
DisclosureSEC source: 0001393726-20-000024 · wf-form4_158232304392163.xml · derivative · entry 1 Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,166 Underlying: Common Stock · 255,166 shares Expires 2030-02-20 F1 · security: The Reporting Person was granted non-qualified stock options to purchase 255,166 shares of common stock of the Registrant, subject to the terms of a Stock Option Agreement between the Registrant and the Reporting person (the "Stock Option Agreement"). F2 · derivative.exercise_date: Exercise of the Stock Option is subject to both (1) a time-based vesting requirement with one-third vesting each of February 20, 2023, 2024 and 2025 and (2) a performance-based vesting requirement that, at any time during the option term, achievement of a 20-day volume weighted average stock price of Registrant's Common Stock, that exceeds the per share book value on an as exchanged basis as of December 31, 2019 (as reported in the Registrant's filings with the Securities and Exchange Commission). F3 · derivative.expiration_date: The Stock Option will expire on the earlier of (1) February 20, 2030 and (2) the date of the termination of the Reporting Person's service with the Registrant for Cause (as defined in the Stock Option Agreement) or the Reporting Person's voluntary termination of service with the Registrant. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 17:13 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
GrantEmployee Stock Option · Derivative | 170,111 | $0.00 Strike: $7.25 | $0.00 |
DisclosureSEC source: 0001393726-20-000026 · wf-form4_158232319418319.xml · derivative · entry 3 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,111 Underlying: Common Stock · 170,111 shares Expires 2030-02-20 F3 · security: The Reporting Person was granted non-qualified stock options to purchase 170,111 shares of common stock of the Registrant, subject to the terms of a Stock Option Agreement between the Registrant and the Reporting person (the "Stock Option Agreement"). F4 · derivative.exercise_date: Exercise of the Stock Option is subject to both (1) a time-based vesting requirement with one-third vesting each of February 20, 2023, 2024 and 2025 and (2) a performance-based vesting requirement that, at any time during the option term, achievement of a 20-day volume weighted average stock price of Registrant's Common Stock, that exceeds the per share book value on an as exchanged basis as of December 31,2019 (as reported in the Registrant's filings with the Securities and Exchange Commission). F5 · derivative.expiration_date: The Stock Option will expire on the earlier of (1) February 20, 2030 and (2) the date of the termination of Michael Barnes's service with the Registrant for Cause (as defined in the Stock Option Agreement) or Michael Barnes's voluntary termination of service with the Registrant. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 17:13 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
GrantCommon Stock | 85,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000026 · wf-form4_158232319418319.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,152,774 F1 · shares: The Reporting Person was granted restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, pursuant to the Issuer's Equity Plan. The restricted stock units will cliff vest on February 15, 2023 upon continuous employment from the grant date until such date, subject to certain terms contained in the Reporting Person's award agreement. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 17:07 UTC |
Bell SandraChief Financial Officer
|
GrantCommon Stock | 16,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000022 · wf-form4_158232284827349.xml · nonDerivative · entry 1 Bell Sandra · CIK 0001447887 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,145 F1 · shares: The Reporting Person was granted restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, pursuant to the Issuer's Equity Plan. The restricted stock units will vest annually in three equal installments on each of February 15, 2021, 2022 and 2023 upon continuous employment from the grant date until such date, subject to certain terms contained in the Reporting Person's award agreement. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 17:05 UTC |
Rifkind Neil CharlesGeneral Counsel and Secretary
|
GrantCommon Stock | 16,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000020 · wf-form4_158232273302092.xml · nonDerivative · entry 1 Rifkind Neil Charles · CIK 0001580685 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,704 F1 · shares: The Reporting Person was granted restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, pursuant to the Issuer's Equity Plan. The restricted stock units will vest annually in three equal installments on each of February 15, 2021, 2022 and 2023 upon continuous employment from the grant date until such date, subject to certain terms contained in the Reporting Person's award agreement. Read SEC document |
| January 31, 2020 Filed Feb 3, 2020 12:44 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 3,403 | $6.85 | $23,310.55 |
DisclosureSEC source: 0001393726-20-000016 · wf-form4_158075187493772.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,067,719 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 21:43 UTC |
Goldwasser LesleyDirector
|
GrantCommon Stock | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000004 · wf-form4_157851977894740.xml · nonDerivative · entry 1 Goldwasser Lesley · CIK 0001465575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,581 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 16:44 UTC |
Mack John EdwardDirector
|
GrantCommon Stock | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000006 · wf-form4_157851987534188.xml · nonDerivative · entry 1 Mack John Edward · CIK 0001381172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,686 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 16:47 UTC |
Friedman Paul MDirector
|
GrantCommon Stock | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000010 · wf-form4_157852005330529.xml · nonDerivative · entry 1 Friedman Paul M · CIK 0001648181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,241 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 16:46 UTC |
Smith Bradley E.Director
|
GrantCommon Stock | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000008 · wf-form4_157851996655671.xml · nonDerivative · entry 1 Smith Bradley E. · CIK 0001579089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,238 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| October 03, 2019 Filed Oct 4, 2019 14:08 UTC |
Goldwasser LesleyDirector
|
GrantCommon Stock | 2,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-19-000160 · wf-form4_157019811080993.xml · nonDerivative · entry 1 Goldwasser Lesley · CIK 0001465575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,273 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| October 03, 2019 Filed Oct 4, 2019 10:07 UTC |
Mack John EdwardDirector
|
GrantCommon Stock | 2,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-19-000158 · wf-form4_157019799983607.xml · nonDerivative · entry 1 Mack John Edward · CIK 0001381172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,378 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| October 03, 2019 Filed Oct 4, 2019 10:10 UTC |
Smith Bradley E.Director
|
GrantCommon Stock | 2,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-19-000162 · wf-form4_157019821194650.xml · nonDerivative · entry 1 Smith Bradley E. · CIK 0001579089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,930 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| October 03, 2019 Filed Oct 4, 2019 10:12 UTC |
Friedman Paul MDirector
|
GrantCommon Stock | 2,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-19-000164 · wf-form4_157019833500631.xml · nonDerivative · entry 1 Friedman Paul M · CIK 0001648181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,933 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. F2 · balance_after: The total direct beneficial ownership reflects a decrease of 4,000 shares due to the transfer of 4,000 shares into the reporting person's Living Trust on 07/26/2019. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 10:04 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 3,128 | $6.83 | $21,364.24 |
DisclosureSEC source: 0001393726-19-000156 · wf-form4_156769222868084.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,064,316 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $6.805 to $6.88, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 10:04 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 4,798 | $6.87 | $32,957.46 |
DisclosureSEC source: 0001393726-19-000156 · wf-form4_156769222868084.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,061,188 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.84 to $6.88, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 30, 2019 Filed Sep 3, 2019 10:34 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 400 | $6.88 | $2,752.00 |
DisclosureSEC source: 0001393726-19-000154 · wf-form4_156752126855251.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,056,390 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 10:34 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 5,600 | $6.86 | $38,421.60 |
DisclosureSEC source: 0001393726-19-000154 · wf-form4_156752126855251.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,055,990 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.83 to $6.88, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 28, 2019 Filed Aug 29, 2019 11:18 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,602 | $6.86 | $17,857.53 |
DisclosureSEC source: 0001393726-19-000152 · wf-form4_156709186817555.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,050,390 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $6.85 to $6.88, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 27, 2019 Filed Aug 29, 2019 11:18 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 6,764 | $6.83 | $46,204.88 |
DisclosureSEC source: 0001393726-19-000152 · wf-form4_156709186817555.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,047,788 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.81 to $6.85, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 26, 2019 Filed Aug 27, 2019 12:30 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,020 | $6.74 | $13,616.82 |
DisclosureSEC source: 0001393726-19-000150 · wf-form4_156692342649255.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,041,024 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $6.63 to $6.85, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 12:30 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 11,786 | $6.61 | $77,881.89 |
DisclosureSEC source: 0001393726-19-000150 · wf-form4_156692342649255.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,039,004 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.55 to $6.65, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 22, 2019 Filed Aug 23, 2019 11:13 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 17,487 | $6.73 | $117,670.02 |
DisclosureSEC source: 0001393726-19-000148 · wf-form4_156657320885428.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,027,218 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $6.60 to $6.87, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 21, 2019 Filed Aug 23, 2019 11:13 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 7,413 | $6.82 | $50,527.01 |
DisclosureSEC source: 0001393726-19-000148 · wf-form4_156657320885428.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,009,731 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.77 to $6.88, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 20, 2019 Filed Aug 21, 2019 10:07 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,446 | $6.75 | $16,503.16 |
DisclosureSEC source: 0001393726-19-000146 · wf-form4_156639641330396.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,002,318 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $6.69 to $6.88, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.